Farshad Abedi

741 total citations
22 papers, 452 citations indexed

About

Farshad Abedi is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Farshad Abedi has authored 22 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Public Health, Environmental and Occupational Health and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Farshad Abedi's work include Corneal Surgery and Treatments (5 papers), Ocular Surface and Contact Lens (5 papers) and Curcumin's Biomedical Applications (2 papers). Farshad Abedi is often cited by papers focused on Corneal Surgery and Treatments (5 papers), Ocular Surface and Contact Lens (5 papers) and Curcumin's Biomedical Applications (2 papers). Farshad Abedi collaborates with scholars based in Iran, United States and Australia. Farshad Abedi's co-authors include Hossein Hosseinzadeh, Bibi Marjan Razavi, Gholamreza Karimi, A. Wallace Hayes, Rüssel J. Reiter, Sepideh Elyasi, Ramin Rezaee, Ahmad Kheirkhah, Bernardo M. Cavalcanti and Pedram Hamrah and has published in prestigious journals such as SHILAP Revista de lepidopterología, Stem Cells and Investigative Ophthalmology & Visual Science.

In The Last Decade

Farshad Abedi

19 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farshad Abedi Iran 9 136 63 49 45 42 22 452
Abu Sufiyan Chhipa India 9 202 1.5× 38 0.6× 31 0.6× 36 0.8× 32 0.8× 17 508
Fatemeh Sadoughi Iran 14 269 2.0× 59 0.9× 33 0.7× 31 0.7× 45 1.1× 32 659
Mahmood Husain Qazi Pakistan 13 253 1.9× 53 0.8× 39 0.8× 23 0.5× 40 1.0× 24 584
Tao Yao China 8 149 1.1× 33 0.5× 45 0.9× 15 0.3× 51 1.2× 10 434
Won Hee Choi South Korea 14 205 1.5× 37 0.6× 30 0.6× 27 0.6× 22 0.5× 35 539
Aya H. El-Kadem Egypt 15 171 1.3× 49 0.8× 17 0.3× 22 0.5× 36 0.9× 23 444
Razieh Avan Iran 11 80 0.6× 52 0.8× 41 0.8× 11 0.2× 39 0.9× 23 432
Angela Sorice Italy 14 230 1.7× 37 0.6× 72 1.5× 25 0.6× 49 1.2× 16 623
Shu‐Chen Cheng Taiwan 11 170 1.3× 42 0.7× 33 0.7× 14 0.3× 49 1.2× 22 493
Giulio Verna Italy 12 219 1.6× 49 0.8× 25 0.5× 18 0.4× 75 1.8× 21 490

Countries citing papers authored by Farshad Abedi

Since Specialization
Citations

This map shows the geographic impact of Farshad Abedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farshad Abedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farshad Abedi more than expected).

Fields of papers citing papers by Farshad Abedi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farshad Abedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farshad Abedi. The network helps show where Farshad Abedi may publish in the future.

Co-authorship network of co-authors of Farshad Abedi

This figure shows the co-authorship network connecting the top 25 collaborators of Farshad Abedi. A scholar is included among the top collaborators of Farshad Abedi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farshad Abedi. Farshad Abedi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shohrati, Majid, et al.. (2025). Effects of curcumin on vascular smooth muscle cells: implications for health and disease. Pharmacological Reports. 77(5). 1232–1246. 3 indexed citations
2.
Tu, Gang, Farshad Abedi, Arthur Chang, et al.. (2025). Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease – A phase 1b clinical trial. The Ocular Surface. 38. 8–13. 2 indexed citations
3.
Abedi, Farshad, et al.. (2025). Renal manifestations of brucellosis: a case report. Journal of Medical Case Reports. 19(1). 108–108.
4.
Abedi, Farshad, et al.. (2025). Insights Into the Pathophysiology of Superior Limbic Keratoconjunctivitis in Chronic Ocular Graft-Versus-Host Disease. Eye & Contact Lens Science & Clinical Practice. 51(7). 290–295.
5.
Tu, Gang, Farshad Abedi, Charlotte E. Joslin, et al.. (2025). Clinical evidence and critical review of mesenchymal stromal cells for corneal and ocular surface diseases. Stem Cells. 43(10).
6.
Abedi, Farshad, et al.. (2024). The protective effects of protocatechuic acid against natural and chemical toxicants: cellular and molecular mechanisms. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(8). 5597–5616. 6 indexed citations
7.
Abedi, Farshad, et al.. (2024). Enhancing treatment strategies for small bowel cancer: a clinical review of targeted therapy and immunotherapy approaches. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(7). 4601–4614. 2 indexed citations
8.
Abedi, Farshad, et al.. (2024). The effects of empagliflozin on ventricular arrhythmias in heart failure patients with an implantable cardioverter-defibrillator: a double-blind randomized controlled trial. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(12). 10191–10201. 2 indexed citations
9.
Salehi, Majid, et al.. (2024). Exploring Hydrogel Nanoparticle Systems for Enhanced Ocular Drug Delivery. Gels. 10(9). 589–589. 15 indexed citations
10.
Abedi, Farshad, et al.. (2024). Albumin: a comprehensive review and practical guideline for clinical use. European Journal of Clinical Pharmacology. 80(8). 1151–1169. 22 indexed citations
11.
Abedi, Farshad, et al.. (2023). HDL-cholesterol concentration and its association with coronary artery calcification: a systematic review and meta-analysis. Lipids in Health and Disease. 22(1). 60–60. 12 indexed citations
12.
Abedi, Farshad, et al.. (2022). The Effect of Heparin and Its Preparations on Disseminated Intravascular Coagulation Mortality and Hospitalization: A Systematic Review. International Journal of Clinical Practice. 2022(1). 2226761–2226761. 4 indexed citations
13.
Abedi, Farshad, et al.. (2022). The Therapeutic Role of Rho Kinase Inhibitor, Fasudil, on Pulmonary Hypertension; a Systematic Review and Meta-Analysis. Drug Research. 73(1). 5–16. 5 indexed citations
15.
Abedi, Farshad, Mahin Ramezani, Reza Dehghan, et al.. (2021). Ethnobotany, Phytochemistry and Pharmacological Features of Centella asiatica: A Comprehensive Review. Advances in experimental medicine and biology. 1308. 451–499. 27 indexed citations
16.
Cox, Stephanie, Ahmad Kheirkhah, Shruti Aggarwal, et al.. (2021). Alterations in corneal nerves in different subtypes of dry eye disease: An in vivo confocal microscopy study. The Ocular Surface. 22. 135–142. 37 indexed citations
17.
Abedi, Farshad, A. Wallace Hayes, Rüssel J. Reiter, & Gholamreza Karimi. (2020). Acute lung injury: The therapeutic role of Rho kinase inhibitors. Pharmacological Research. 155. 104736–104736. 100 indexed citations
18.
Abedi, Farshad, et al.. (2020). MicroRNAs and SARS-CoV-2 life cycle, pathogenesis, and mutations: biomarkers or therapeutic agents?. Cell Cycle. 20(2). 143–153. 37 indexed citations
19.
Abedi, Farshad, Bibi Marjan Razavi, & Hossein Hosseinzadeh. (2019). A review on gentisic acid as a plant derived phenolic acid and metabolite of aspirin: Comprehensive pharmacology, toxicology, and some pharmaceutical aspects. Phytotherapy Research. 34(4). 729–741. 130 indexed citations
20.
Abedi, Farshad, et al.. (2012). Gene Variants in the HTRA1 and ARMS2 genes and Outcome of Anti-VEGF Treatment in Neovascular AMD. Investigative Ophthalmology & Visual Science. 53(14). 2931–2931. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026